CIP
ARNA

Cornerstone Investment Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Cornerstone Investment Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,750
Closed -$280K – 233
2020
Q3 		$280K Hold
3,750
– – 0.02% 91
2020
Q2 		$236K Buy
+3,750
New +$206K 0.02% 101

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cornerstone Investment Partners's ARNA Position: Q4 2020 in Review

Cornerstone Investment Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 3,750 shares — an estimated $280K sold.

Cornerstone Investment Partners first reported a position in ARNA in Q2 2020 and held it in 2 quarters. The position peaked at $280K in Q3 2020. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Cornerstone Investment Partners reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Cornerstone Investment Partners sold 3,750 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $280K.
  • Cornerstone Investment Partners first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 2 quarters.
  • Cornerstone Investment Partners's Arena Pharmaceuticals Inc position peaked at $280K in Q3 2020.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Cornerstone Investment Partners's 13F filing for Q4 2020, filed 28 Jan 2021.